For citations:
Nechushkina V.M., Khokhlova S.V., Nosov D.A., Ulrikh E.A., Kolomiets L.A., Rumyantsev A.A., Raskin G.A. Current approaches to first-line therapy for endometrial cancer: the role of lenvatinib and pembrolizumab combination therapy. Tumors of female reproductive system. 2025;21(2):127-134. (In Russ.) https://doi.org/10.17650/1994-4098-2025-21-2-127-134


































